Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.840
-0.320 (-10.13%)
At close: Nov 20, 2024, 4:00 PM
2.860
+0.020 (0.70%)
Pre-market: Nov 21, 2024, 7:27 AM EST
Sonoma Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 13.55 | 12.74 | 13.27 | 12.63 | 18.63 | 17.93 | Upgrade
|
| Revenue Growth (YoY) | 11.81% | -4.05% | 5.10% | -32.21% | 3.91% | -5.49% | Upgrade
|
| Cost of Revenue | 8.33 | 7.99 | 8.8 | 8.64 | 12.07 | 9.81 | Upgrade
|
| Gross Profit | 5.22 | 4.75 | 4.48 | 3.99 | 6.56 | 8.12 | Upgrade
|
| Selling, General & Admin | 7.51 | 7.58 | 8.84 | 9.76 | 9.45 | 14.17 | Upgrade
|
| Research & Development | 1.99 | 1.87 | 0.21 | 0.13 | 0.56 | 1.34 | Upgrade
|
| Operating Expenses | 9.49 | 9.45 | 9.05 | 9.88 | 10.01 | 15.51 | Upgrade
|
| Operating Income | -4.28 | -4.7 | -4.57 | -5.89 | -3.45 | -7.39 | Upgrade
|
| Interest Expense | - | - | - | -0.01 | - | -0.02 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0 | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.83 | -0.83 | -0.69 | -0.58 | -0.69 | 0.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.36 | 0.5 | 0.08 | 0.19 | 0.1 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -3.74 | -5.03 | -5.18 | -6.29 | -4.04 | -7.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.15 | 0.14 | 3.57 | Upgrade
|
| Other Unusual Items | - | - | - | 0.72 | - | - | Upgrade
|
| Pretax Income | -3.74 | -5.03 | -5.18 | -5.42 | -3.9 | -3.54 | Upgrade
|
| Income Tax Expense | -0.06 | -0.2 | -0.03 | -0.33 | 0.71 | 0.03 | Upgrade
|
| Earnings From Continuing Operations | -3.69 | -4.84 | -5.15 | -5.09 | -4.62 | -3.57 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 0.67 | 0.27 | Upgrade
|
| Net Income | -3.69 | -4.84 | -5.15 | -5.09 | -3.95 | -3.31 | Upgrade
|
| Net Income to Common | -3.69 | -4.84 | -5.15 | -5.09 | -3.95 | -3.31 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 265.61% | 167.83% | 27.93% | 32.92% | 35.14% | 59.85% | Upgrade
|
| EPS (Basic) | -4.61 | -10.64 | -30.35 | -38.34 | -39.58 | -44.79 | Upgrade
|
| EPS (Diluted) | -4.61 | -10.64 | -30.35 | -38.34 | -39.58 | -44.79 | Upgrade
|
| Free Cash Flow | -1.54 | -2.42 | -6.42 | -4.39 | -3.56 | -4.8 | Upgrade
|
| Free Cash Flow Per Share | -1.92 | -5.31 | -37.84 | -33.06 | -35.64 | -64.96 | Upgrade
|
| Gross Margin | 38.52% | 37.26% | 33.73% | 31.62% | 35.21% | 45.30% | Upgrade
|
| Operating Margin | -31.56% | -36.91% | -34.43% | -46.62% | -18.51% | -41.22% | Upgrade
|
| Profit Margin | -27.21% | -37.97% | -38.81% | -40.28% | -21.20% | -18.45% | Upgrade
|
| Free Cash Flow Margin | -11.36% | -18.96% | -48.38% | -34.72% | -19.09% | -26.76% | Upgrade
|
| EBITDA | -4.12 | -4.53 | -4.45 | -5.7 | -3.22 | -7.08 | Upgrade
|
| EBITDA Margin | -30.38% | -35.53% | -33.49% | -45.15% | -17.30% | -39.48% | Upgrade
|
| D&A For EBITDA | 0.16 | 0.18 | 0.13 | 0.19 | 0.23 | 0.31 | Upgrade
|
| EBIT | -4.28 | -4.7 | -4.57 | -5.89 | -3.45 | -7.39 | Upgrade
|
| EBIT Margin | -31.56% | -36.91% | -34.43% | -46.62% | -18.51% | -41.22% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 17.93 | Upgrade
|
| Advertising Expenses | - | 0.16 | 0.16 | 0.09 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.